These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30058778)

  • 1. Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers.
    Taniai M; Hashimoto E; Tobari M; Kodama K; Tokushige K; Yamamoto M; Takayama T; Sugitani M; Sano K; Kondo F; Fukusato T
    Hepatol Res; 2018 Nov; 48(12):947-955. PubMed ID: 30058778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
    Shibahara J; Ando S; Sakamoto Y; Kokudo N; Fukayama M
    Histopathology; 2014 Jun; 64(7):951-62. PubMed ID: 24898917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study.
    Ando S; Shibahara J; Hayashi A; Fukayama M
    Virchows Arch; 2015 Nov; 467(5):535-42. PubMed ID: 26311355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatohepatitic Variant of Hepatocellular Carcinoma: A Focused Review.
    Olofson AM; Gonzalo DH; Chang M; Liu X
    Gastroenterology Res; 2018 Dec; 11(6):391-396. PubMed ID: 30627261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-Enhanced Imaging Features and Clinicopathological Investigation of Steatohepatitic Hepatocellular Carcinoma.
    Chen K; Xu Y; Dong Y; Han H; Mao F; Wang H; Song X; Luo R; Wang WP
    Diagnostics (Basel); 2023 Apr; 13(7):. PubMed ID: 37046555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatotic and Steatohepatitic Hepatocellular Carcinomas: Features in a Series With Predominantly Viral Etiology.
    Aykutlu U; Argon A; Orman M; Ulukaya S; Zeytunlu M; Karasu Z; Günşar F; Nart D; Akarca U; Yilmaz F
    Am J Surg Pathol; 2021 Sep; 45(9):1252-1263. PubMed ID: 33826548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
    Lee JS; Yoo JE; Kim H; Rhee H; Koh MJ; Nahm JH; Choi JS; Lee KH; Park YN
    PLoS One; 2017; 12(3):e0171922. PubMed ID: 28273155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatohepatitis-Like Changes in Hepatocellular Adenoma.
    Liu Y; Zen Y; Yeh MM
    Am J Clin Pathol; 2020 Sep; 154(4):525-532. PubMed ID: 32561910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatotic hepatocellular carcinoma: Association of MRI findings to underlying liver disease and clinicopathological characteristics.
    Park JH; Park YN; Kim MJ; Park MS; Choi JY; Chung YE; Rhee H
    Liver Int; 2023 Jun; 43(6):1332-1344. PubMed ID: 37088983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological assessment of steatohepatitic hepatocellular carcinoma.
    Yamaoka K; Saitoh S; Kinowaki K; Fujiyama S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki F; Suzuki Y; Arase Y; Ikeda K; Fukusato T; Kumada H
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101799. PubMed ID: 34500120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological overview of steatohepatitic hepatocellular carcinoma in a surgical series.
    Trapani L; Beaufrère A; Hobeika C; Codjia T; Albuquerque M; Bouattour M; Lesurtel M; Cauchy F; Paradis V
    Histopathology; 2023 Oct; 83(4):526-537. PubMed ID: 37222200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.
    Alexander J; Torbenson M; Wu TT; Yeh MM
    J Gastroenterol Hepatol; 2013 May; 28(5):848-54. PubMed ID: 23302015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.
    Jain D; Nayak NC; Kumaran V; Saigal S
    Arch Pathol Lab Med; 2013 Jul; 137(7):961-6. PubMed ID: 23808468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.
    Salomao M; Remotti H; Vaughan R; Siegel AB; Lefkowitch JH; Moreira RK
    Hum Pathol; 2012 May; 43(5):737-46. PubMed ID: 22018903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.
    Tiniakos DG; Maurício J; Reeves HL
    Adv Exp Med Biol; 2018; 1032():55-69. PubMed ID: 30362090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
    Viganò L; Conci S; Cescon M; Fava C; Capelli P; D'Errico A; Torzilli G; Di Tommaso L; Giuliante F; Vecchio FM; Salizzoni M; David E; Pinna AD; Guglielmi A; Capussotti L
    J Hepatol; 2015 Jul; 63(1):93-101. PubMed ID: 25646890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.